Objective: The present study was to examine whether endogenous nitric oxide (NO) plays a role in the regulation of vascular stiffness. Methods: Pulse wave velocity (PWV) was determined as the time delay between the foot of pressure waves recorded simultaneously at the aortic arch and abdominal aorta (just above the bifurcation) in anesthetized Sprague-Dawley rats. A decrease in vascular compliance results in an increase in PWV. Results: A bolus injection of a NO synthase inhibitor, L-NAME (30 mg / kg), significantly increased PWV, accompanied by an increase in blood pressure. Since changes in blood pressure are known to affect PWV, phenylephrine (PE) was administered to mimic the blood pressure changes induced by L-NAME, thus compensating for the pressure-dependent component of the PWV changes. At each given level of mean arterial pressure (MAP), PWV was significantly higher with L-NAME than with PE treatment, suggesting that acute withdrawal of endogenous NO reduces aortic compliance independent of changes in MAP. In rats chronically treated with L-NAME (0.5 g / l in drinking water) for 3 weeks, PWV was even higher than those acutely treated with L-NAME (at MAP5150 mmHg). This additional increase in vascular stiffness may be due to the remodeling of the vascular wall as a result of chronic NOS inhibition and hypertension. Conclusion: These data demonstrate that NO modulates vascular compliance independent of blood pressure changes and that an intact endogenous NO system is required to maintain normal vascular compliance.
Introduction
SHEP study, increased vascular stiffness was believed to be the cause of an increase in systolic and pulse pressures, Windkessel function, or elastic behavior of the arterial which were positively correlated to increased stroke and system, is physiologically important because it converts ''all-cause mortality'' [6] . Many clinicians are now using the pulsatile cardiac ejection into a nearly continuous flow. vascular stiffness (compliance, elasticity or distensibility) This improves sub-endocardial perfusion during diastole as an index for cardiovascular disease. The stiffer vessel is and maintains a sustained perfusion to the peripheral less elastic, distensible or compliant. Vascular stiffness can organs. It also results in a reduction in systolic pressure be estimated by measuring the pulse wave velocity (PWV) and a slight increase of diastolic pressure, thus lowering [7, 8] . The stiffer the vessel, the faster the pressure pulse cardiac afterload [1] . When the arterial system becomes wave moves along a vessel. Thus, PWV has been used as a stiffer or less elastic in cardiovascular diseases (i.e.
surrogate marker for vascular diseases [9,10], including atherosclerosis, diabetes and hypertension), vascular comatherosclerosis [11] . pliance or windkessel function is reduced. This impairs
The endothelium has many physiologically important tissue perfusion and increases cardiac afterload, leading to roles. Substances released from the vascular endothelium, cardiac hypertrophy [2] [3] [4] [5] . In a recent Framingham and such as nitric oxide (NO), modulate vascular tone, attenuate smooth muscle proliferation, and inhibit platelet function [12] [13] [14] . Dysfunction of the endothelium is associated with and / or contributes to the progression of 2.1.2. Experimental procedures cardiovascular diseases such as atherosclerosis [15] , hyMeasurements of aortic PWV were conducted similarly pertension [16] , and heart failure [17] . It has been reported to what has been described in our previous publication [8] , recently that endothelial dysfunction is also associated with as well as by other investigators [7, 19] . Briefly, pulse an increase in vascular stiffness [18] . However it is not pressure waves from the two Millar transducers were clear whether endothelial dysfunction can increase vascular simultaneously imported to a Gould amplifier (Gould, stiffness independent of changes in blood pressure or Valley View, OH) and displayed on a data acquisition changes in the morphology of the vasculature. This is system (PowerLab, 16 / s, ADInstruments, Australia) at a clinically important, since Glasser et al. summarized in a sampling rate of 1000 Hz. The sampling rate and frereview that therapies which directly target vascular comquency response of the Millar transducers are capable of pliance may be more beneficial in reducing cardiovascular providing high fidelity pressure wave forms and high risk factors than agents which just lower blood pressure resolution measurements. After the experiment was com- [2] . Thus, we hypothesized that the absence of NO, a pleted, the animal was euthanized with pentobarbital major consequence of endothelial dysfunction, may directsodium (200 mg / kg) and the full length of the aorta was ly contribute to the increase of vascular stiffness.
exposed. A damp silk thread was placed along the contour In the present study, we attempted to determine if of the aorta and marked at the tips of the two pressure endothelial dysfunction, induced acutely or chronically by transducers. The thread was then removed and laid straight v pharmacologically inhibiting NO production with N -nifor measurement of the distance between the two marks. tro-L-arginine methyl ester (L-NAME), could affect aortic This is the pulse wave propagation distance, and was used stiffness in rats. PWV was measured to estimate the aortic to calculate PWV (see below). stiffness. Since L-NAME treatment increases blood presPhenylephrine (PE, 10-30 mg / kg / min, Sigma, St. sure which has been known to affect PWV, phenylephrine Louis, MO) was infused intravenously via a catheter in the (PE) and isopretenorol (ISO) were used to standardize jugular vein. After blood pressure reached plateau during blood pressure levels among different treatments, thereby PE infusion, isoproterenol (ISO, 10 mg / kg, Sigma, St. removing the pressure component that contributes to PWV Louis, MO) was injected via a catheter in the femoral vein changes after L-NAME treatment.
to decrease blood pressure to the baseline. Infusion of PE was then stopped. When blood pressure was returned to the v baseline, N -nitro-L-arginine methyl ester (L-NAME, 30 mg / kg, Sigma, St. Louis, MO), a non-specific nitric oxide 2. Methods synthase (NOS) inhibitor, was injected intravenously to block NO production. After a period of 30 min when blood Experiments were performed in male Crl:CD(SD)-hrBR pressure was increased and reached a plateau, an intravenrats weighing 300-400 g (Charles River Laboratories, ous bolus injection of ISO (10 mg / kg) was given to Hollister, CA). Animals were kept in a room at controlled decrease blood pressure. Since PWV is known to be temperature (248C) and lighting (14:10-h light-dark cycle) significantly affected by changes in blood pressure and with free access to food and tap water. All experimental L-NAME increases blood pressure, with the manipulation procedures were approved by the Animal Care and Use of blood pressure by PE and ISO, PWV was able to be Committee and were conducted in accordance with Nationcompared between PE and L-NAME treatments at the same al Institutes of Health Guidelines for the care and use of multiple given levels of MAP ranging from 110 to 190 animals. mmHg in 10 mmHg increments. This method eliminated the effect of pressure changes on PWV and thus, differen-2.1. Experimental procedures tiate the effects of acute NO withdrawal from the blood pressure component on modulation of PWV. Chronic 2.1.1. Surgical preparation treatment of L-NAME was administered via the drinking Animals were anesthetized with an intraperitoneal inwater (0.5 g / l) for 3 weeks, and PWV was then measured. jection of pentobarbital sodium (70 mg / kg, Butler, Union
An intravenous bolus injection of ISO (10 mg / kg) was City, CA) and placed on a heated water pad at 378C to also used to decrease blood pressure to the same level (150 maintain body temperature. The right jugular vein and the mmHg) for comparison of PWV across groups. left femoral vein were catheterized with polyethylene tubings (PE50, VWR, San Francisco, CA) for the adminis-2.2. Measurement of pulse wave velocity tration of different pharmacological agents. For measurement of PWV, two 1.4 Fr. Millar Mikro-tip pressure
As illustrated in Fig. 1 , PWV was calculated by dividing transducers (Millar, Houston, TX) were implanted, one in the propagation distance (L) by propagation time (t) in the aortic arch via the left carotid artery, and one in the units of meters per second. The propagation time was abdominal aorta just proximal to the iliac bifurcation via determined using three different techniques as described the left femoral artery.
below:
from person to person; and (2) lack of automation, since it is based on personal judgment rather than formulas. Although other investigators also tried to use formulabased methods to estimate foot to foot measurements in animals, these methods have been shown less reliable than foot to foot method [19] . Instead of trying to estimate the foot, DPC method identifies diastolic phase center by averaging the times at which the pulse wave crosses 1 mmHg above the minimum diastolic pressure on the downslope and upslope of the pressure signal (Fig. 2 ). The propagation time was then determined by subtracting the time difference between the diastolic phase centers of the proximal and distal waves. A total of five to nine cycles were averaged as one propagation time. Like the foot to foot method, the DPC method still utilizes the diastolic phase of the cycle, because it has been shown to be less affected by distortion than other parts of the cardiac cycle Fig. 1 . Representation of the proximal (aortic arch) and distal (abdominal aorta) pressure wave forms. PWV is calculated by dividing the propaga- [20] . This method for determining PWV has proven to be tion distance (L) by the propagation time (t). Propagation time is the both efficient and reliable, as it is highly correlated to the difference in time between the beginning of the upstroke of the two traditional manual foot to foot method ( Fig. 3b) , as well as pulsatile wave forms.
to the average cycle method (Fig. 3c ).
2.2.1. Manual foot to foot 2.3. Calculations and statistics As described in details by Wang et al. [8] , the propagation time for the pulse wave moving from the aortic arch to 2.3.1. Hemodynamic parameters the abdominal aorta was measured manually by the time Mean arterial pressure (MAP), systolic arterial pressure delay between the upstrokes (foot) of each pressure wave (SAP), diastolic arterial pressure (DAP), and pulse presfront ( Fig. 1) . At least ten normal consecutive cardiac sure (PP) were determined from measurements made by cycles were individually measured and averaged as one the proximal pressure transducer located in the aortic arch PWV point. If an abnormal waveform fell within the ten and were calculated by using Chart software (PowerLab, cycles measured, it was rejected and the next viable ADInstruments, Castle Hill, New South Wales, Australia). waveform was measured. Although the manual foot to foot method is considered a reliable method for determining 2.3.2. b index PWV [19] and has been widely used by other investigators While MAP was normalized between groups for [8, 19] , it is a very labor intensive method. Thus, the measuring PWV, differences in DAP were still seen in the following two additional techniques were developed for present study. It has been known that PWV is most analyzing propagation time.
Averaged cycle foot to foot
Raw data obtained from both the proximal and distal pressure transducers were imported into Excel (Microsoft, Seattle, WA) and the waveforms of five to nine cardiac cycles from each transducer were overlapped using a formula based on average heart rate of these cycles. Instead of analyzing PWV from several cardiac cycles individually and averaging the results, a single foot to foot propagation time was measured from the averaged cycle. This method proved to be very efficient. It is also very reliable because the same data points measured by using this method were highly correlated to those by the manual foot to foot method (Fig. 3a) . MAP ranging from 110 to 190 mmHg in 10 mmHg increments. The data from each individual animal were plotted in Fig. 4 . As blood pressure gradually increased during PE infusion, PWV also increased in a highly correlated manner. Once blood pressure reached plateau during PE infusion, ISO was given as a bolus to normalize blood pressure. When blood pressure reached baseline levels after bolus ISO during PE infusion, PWV was also reduced to its original baseline level (Fig. 5) . Acute treatment with L-NAME increased both blood pressure and PWV (Fig. 6A) . In order to isolate the impact sensitive to the changes in DAP [11, 21] . Therefore, b of blood pressure on PWV, in a separate group of rats, index was calculated for normalizing DAP. b index is blood pressure was increased by PE infusion (peak MAP5 2 calculated with the following formula: 2.11*PWV / dias-172.664.2 mHg) to the level close to that induced by tolic pressure.
L-NAME (peak MAP5163.463.1 mmHg). At every given level of MAP measured, PWV was higher with L-NAME 2.3.3. Statistics than with PE treatment. No differences in MAP were Results are presented as mean6standard error for the observed since measurements were taken at determined number of animals (n) indicated. Single comparisons of the levels of MAP for each individual animal. However, DAP mean values were performed by a Student's t-test. Multiple was significantly higher, SAP significantly lower, and comparisons of the mean values were performed by a consequently, pulse pressure significantly lower with Ltwo-way ANOVA followed, if significance was indicated, NAME than with PE treatment (Table 1 ). To normalize the by a subsequent Student-Newman-Keuls test for repeated influence of diastolic pressure on PWV, b index was comparisons. Differences were considered statistically calculated which again showed significantly higher with significant when the P-value was ,0.05. The statistical L-NAME compared to PE treatment at every given level of analysis was processed with Statview software (SAS MAP measured (Fig. 6B) . Institute Inc., Cary, NC).
Chronic inhibition of nitric oxide production increases PWV

Results
Chronic treatment with L-NAME for 3 weeks resulted in 3.1. Effect of blood pressure on PWV sustained hypertension and increased PWV. In order to normalize blood pressure for comparison of PWV among Intravenous infusion of PE resulted in a gradual increase all groups at the same pressure, ISO was given. PWV was in blood pressure. PWV was obtained at given levels of then measured when MAP was at 150 mmHg in all groups. Both PWV and b index were significantly higher with L-NAME treatment rats were acutely treated with L-NAME than with PE.
compared to PE at each given level of MAP, P,0.01.
Chronic L-NAME treatment significantly increased PWV by an additional 8% above the acute L-NAME group. the same blood pressure level for all groups. The present results revealed that PWV was significantly higher at each 4. Discussion given pressure level when the rats were acutely treated with L-NAME compared to those with PE. This additional The main findings of this study are that acute inhibition increase in PWV by L-NAME over PE treatment, thereof nitric oxide synthase by L-NAME increased aortic fore, was blood pressure independent, and thus, could be stiffness (measured by PWV) independent of the concomiattributed to the acute withdraw of NO. In support of this tant increase in blood pressure, indicating that NO plays a view, the present result further demonstrated that the role in modulating aortic compliance. Chronic treatment of pressure component contributing to the increase in PWV L-NAME for 3 weeks further increased PWV. This cominduced by PE could be completely offset when blood ponent of the increase in aortic stiffness is probably due, at pressure was reduced to the baseline level by ISO. least in part, to an abnormal remodeling in the vascular
The influence of blood pressure on aortic compliance wall resulting from the long-term absence of NO, as well could be via the following mechanism. There are three as chronic hypertension.
major elements (elastin, collagen and smooth muscle) in As we and other authors [20] [21] [22] [23] have demonstrated, the vascular wall contributing in different proportions to changes in blood pressure also affect compliance of the the vascular compliance depending on transmural pressures aortic conduit vessel. Since both acute and chronic treatthat alter forces exerted on the various elements. Elastin 6 3 ment of L-NAME increased blood pressure, the concomihas a very low elastic modulus (5310 dynes / cm ) giving tant increase in PWV observed in both groups must be the aorta its distensibility. Collagen has a very high elastic 6 3 attributed, at least in part, to the increase in blood pressure. modulus (900310 dynes / cm ) giving the vessel wall Therefore, PE was used to increase and ISO to decrease strength during high transmural pressure. These two eleblood pressure so that MAP could be normalized across ments affect vascular compliance by their ratio in the the different treatment groups. PWV was then compared at vessel wall, which is different along the aortic tree. There is more elastin in the aortic arch and more collagen in the pliance. The most useful method for measuring the funcdistal conductance arteries [20] . Transmural pressure actional contribution of smooth muscle to the elastic modulus ross the vessel determines the distribution of the stress is isometric analysis [20, 22] . Using this method, it has placed on elastin and collagen. At lower transmural been shown that activation of the smooth muscle with PE pressure, much of the stress placed on the vessel wall is reduces vascular compliance. On the other hand, dilating absorbed by the compliant elastin. At higher transmural vessels with calcium channel antagonists and nitropressure, the vessel wall expands, recruiting more nonvasodilators increases compliance more than diuretics do compliant collagen. The increased stress on collagen even though they lower blood pressure similarly makes the vessel less compliant or stiffer [20, 22] . [1, 2, 22, [24] [25] [26] . This suggests that decreasing vascular tone The role of the smooth muscle in vascular compliance is of the conductance vessel can increase vascular comcontroversial. The smooth muscle has a low elastic pliance independent of blood pressure [20, 27] . Thus, while 6 3 modulus (1-8310 dynes / cm ) and only makes up about elastin and collagen passively contribute to elasticity or one third of the elasticity of the aortic wall. Therefore, stiffness of the vessel, the smooth muscle appears to activation of the aortic smooth muscle has been considered actively modulate vascular compliance. negligible in affecting vascular stiffness. However, invesEndothelial dysfunction and vascular stiffness have both tigators using different methods for measuring vessel been implicated in several vascular diseases that reduce elastic modulus have indicated that the smooth muscle is cardiac function. Both tend to increase systolic pressure, capable of contributing significantly to vascular compulse pressure and reduce subendocardial perfusion. Studies have shown that endothelial dysfunction is found early in atherosclerosis and may be a precursor to increased vascular stiffness by consequential constriction of the smooth muscle in the vascular wall. Experimental evidence supports that smooth muscle contribution to the elastic modulus is more important than its inherent physical properties suggests. Therefore, changes in vascular tone due to endothelial dysfunction may be an important factor independent of blood pressure leading to vascular stiffness and cardiovascular disease. The endothelium modulates vascular tone through substances such as NO [28, 29] . Dysfunction of the endothelium in cardiovascular diseases can disrupt the signal transduction pathways, reducing the endothelium's ability to modulate vascular tone and perhaps even vascular compliance [30, 31] . Indeed, Ramsey et al., observed that in chronic heart failure patients with endothelial dysfunction, the endothelium NO mediated increase in conduit artery distensibility is impaired, while endothelium NO independent increase in Fig. 7 . Effect of phenylephrine (PE) and acute or chronic L-NAME distensibility is retained [17] . Thus, endothelium dysfunctreatment on pulse wave velocity when mean arterial blood pressure was tion is related to the reduction in vascular compliance. The normalized with isoproterenol to 150 mmHg in all three groups. *, P,0.05 vs. PE. †, P,0.01, vs. PE and acute L-NAME.
present study tested the hypothesis that NO functionally modulates vascular compliance. Indeed, our results demonthickening and increase in intima / media or wall / lumen strated that treatment with L-NAME for 30 min signifiratios in the mesenteric microvascular beds, arterioles, cantly increased PWV, which was greater than that induced coronary arteries, and aorta [34] [35] [36] [37] [38] [39] . Such remodeling of by PE. The mechanisms to account for this are still the vasculature could occur as early as 3-4 weeks followunclear, but higher smooth muscle tone in L-NAME than ing L-NAME treatment [38] . In addition, chronic hyperten-PE treatment may be a possible explanation. Although sion could also cause structural changes in the vascular PWV was compared at the same given MAP levels wall [20] . between PE and L-NAME treatment in the present study, In summary, the present study demonstrated that there since L-NAME has been shown to reduce cardiac output in are four different components contributing to vascular rats [32] , peripheral vascular resistance (vascular tone) stiffness as illustrated in Fig. 8 . These include: (1) a basal must be higher with L-NAME than with PE treatment. The component at normal blood pressure level; (2) a pressure fact that at each given mean blood pressure level, systolic component increases PWV when blood pressure is elevated pressure was lower (indicating a lower cardiac output) and to 150 mmHg by pharmacological agents; (3) increased diastolic pressure higher (indicating a higher peripheral vascular smooth muscle tone due to acute inhibition of NO vascular resistance or tone) after L-NAME compared to contributes to an increase in PWV that is independent of PE, suggests that L-NAME may increase vascular tone blood pressure; and (4) vascular remodeling, presumably more than PE does even though MAP is the same. Thus, it resulting from chronic inhibition of NO production, further supports the view that NO modulates vascular compliance increases aortic stiffness. via modulation of vascular tone. However, L-NAME has also been shown having non-specific effects, such as inhibiting the muscarinic receptor antagonist [33] . But it is
